These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 22492986)

  • 21. Curcumin-induced mitotic spindle defect and cell cycle arrest in human bladder cancer cells occurs partly through inhibition of aurora A.
    Liu HS; Ke CS; Cheng HC; Huang CY; Su CL
    Mol Pharmacol; 2011 Oct; 80(4):638-46. PubMed ID: 21757545
    [TBL] [Abstract][Full Text] [Related]  

  • 22. LIMK2 acts as an oncogene in bladder cancer and its functional SNP in the microRNA-135a binding site affects bladder cancer risk.
    Wang W; Yang C; Nie H; Qiu X; Zhang L; Xiao Y; Zhou W; Zeng Q; Zhang X; Wu Y; Liu J; Ying M
    Int J Cancer; 2019 Mar; 144(6):1345-1355. PubMed ID: 30006972
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of mTOR activity restores tamoxifen response in breast cancer cells with aberrant Akt Activity.
    deGraffenried LA; Friedrichs WE; Russell DH; Donzis EJ; Middleton AK; Silva JM; Roth RA; Hidalgo M
    Clin Cancer Res; 2004 Dec; 10(23):8059-67. PubMed ID: 15585641
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Aurora kinases: new targets for cancer therapy.
    Carvajal RD; Tse A; Schwartz GK
    Clin Cancer Res; 2006 Dec; 12(23):6869-75. PubMed ID: 17145803
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mitotic kinase Aurora-A phosphorylates RASSF1A and modulates RASSF1A-mediated microtubule interaction and M-phase cell cycle regulation.
    Rong R; Jiang LY; Sheikh MS; Huang Y
    Oncogene; 2007 Dec; 26(55):7700-8. PubMed ID: 17563743
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oncogenic function of microtubule end-binding protein 1 in breast cancer.
    Dong X; Liu F; Sun L; Liu M; Li D; Su D; Zhu Z; Dong JT; Fu L; Zhou J
    J Pathol; 2010 Feb; 220(3):361-9. PubMed ID: 19967727
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Aurora A regulates prometaphase progression by inhibiting the ability of RASSF1A to suppress APC-Cdc20 activity.
    Song SJ; Song MS; Kim SJ; Kim SY; Kwon SH; Kim JG; Calvisi DF; Kang D; Lim DS
    Cancer Res; 2009 Mar; 69(6):2314-23. PubMed ID: 19276349
    [TBL] [Abstract][Full Text] [Related]  

  • 28. LIM kinase 2 is widely expressed in all tissues.
    Acevedo K; Moussi N; Li R; Soo P; Bernard O
    J Histochem Cytochem; 2006 May; 54(5):487-501. PubMed ID: 16399995
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Suppression of Aurora-A by RNA interference inhibits laryngeal cancer Hep-2 cell growth].
    Zhang H; Chen XH; Cai CP; Wang SL; Liu BY; Zhou L
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2012 Jan; 47(1):58-63. PubMed ID: 22455777
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Inhibition of PDK1 gene expression in esophageal cancer EC9706 cells by RNA interference and its effect on their malignant biological behavior].
    Yu J; Chen KS; Li YN; Yang J; Zhao L
    Zhonghua Zhong Liu Za Zhi; 2011 Jun; 33(6):410-4. PubMed ID: 21875479
    [TBL] [Abstract][Full Text] [Related]  

  • 31. SNS-314, a pan-Aurora kinase inhibitor, shows potent anti-tumor activity and dosing flexibility in vivo.
    Arbitrario JP; Belmont BJ; Evanchik MJ; Flanagan WM; Fucini RV; Hansen SK; Harris SO; Hashash A; Hoch U; Hogan JN; Howlett AR; Jacobs JW; Lam JW; Ritchie SC; Romanowski MJ; Silverman JA; Stockett DE; Teague JN; Zimmerman KM; Taverna P
    Cancer Chemother Pharmacol; 2010 Mar; 65(4):707-17. PubMed ID: 19649632
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Protein kinase D1 stimulates proliferation and enhances tumorigenesis of MCF-7 human breast cancer cells through a MEK/ERK-dependent signaling pathway.
    Karam M; Legay C; Auclair C; Ricort JM
    Exp Cell Res; 2012 Mar; 318(5):558-69. PubMed ID: 22245102
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Androgen receptor regulation of G1 cyclin and cyclin-dependent kinase function in the CWR22 human prostate cancer xenograft.
    Gregory CW; Johnson RT; Presnell SC; Mohler JL; French FS
    J Androl; 2001; 22(4):537-48. PubMed ID: 11451350
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Aurora-A regulates autophagy through the Akt pathway in human prostate cancer.
    Zhang S; Li J; Zhou G; Mu D; Yan J; Xing J; Yao Z; Sheng H; Li D; Lv C; Sun B; Hong Q; Guo H
    Cancer Biomark; 2017; 19(1):27-34. PubMed ID: 28269749
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of LIMK2 as a therapeutic target in castration resistant prostate cancer.
    Nikhil K; Chang L; Viccaro K; Jacobsen M; McGuire C; Satapathy SR; Tandiary M; Broman MM; Cresswell G; He YJ; Sandusky GE; Ratliff TL; Chowdhury D; Shah K
    Cancer Lett; 2019 Apr; 448():182-196. PubMed ID: 30716360
    [TBL] [Abstract][Full Text] [Related]  

  • 36. LIMK2 promotes melanoma tumor growth and metastasis through G3BP1-ESM1 pathway-mediated apoptosis inhibition.
    Malvi P; Reddy DS; Kumar R; Chava S; Burela S; Parajuli K; Zhang X; Wajapeyee N
    Oncogene; 2023 May; 42(18):1478-1491. PubMed ID: 36922679
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ROCK1 and LIMK2 interact in spread but not blebbing cancer cells.
    Shea KF; Wells CM; Garner AP; Jones GE
    PLoS One; 2008; 3(10):e3398. PubMed ID: 18852895
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Involvement of elevated expression of multiple cell-cycle regulator, DTL/RAMP (denticleless/RA-regulated nuclear matrix associated protein), in the growth of breast cancer cells.
    Ueki T; Nishidate T; Park JH; Lin ML; Shimo A; Hirata K; Nakamura Y; Katagiri T
    Oncogene; 2008 Sep; 27(43):5672-83. PubMed ID: 18542055
    [TBL] [Abstract][Full Text] [Related]  

  • 39. LIMK2: A Multifaceted kinase with pleiotropic roles in human physiology and pathologies.
    Shah K; Cook M
    Cancer Lett; 2023 Jul; 565():216207. PubMed ID: 37141984
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Keratinocyte migration in the developing eyelid requires LIMK2.
    Rice DS; Hansen GM; Liu F; Crist MJ; Newhouse MM; Potter D; Xu N; Abuin A; Vogel PJ; Zambrowicz BP
    PLoS One; 2012; 7(10):e47168. PubMed ID: 23071748
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.